Toll	B:C0670896
-	I:C0670896
like	I:C0670896
receptors	I:C0670896
genes	O
polymorphisms	O
and	O
the	O
occurrence	O
of	O
HCMV	O
infection	I:C0010823
among	O
pregnant	O
women	I:C0033011
.	O

Toll	O
-	I:C0670896
like	I:C0670896
receptors	I:C0670896
genes	O
polymorphisms	O
and	O
the	O
occurrence	O
of	O
HCMV	B:C0010823
infection	I:C0010823
among	O
pregnant	O
women	I:C0033011
.	O

Toll	O
-	I:C0670896
like	I:C0670896
receptors	I:C0670896
genes	O
polymorphisms	O
and	O
the	O
occurrence	O
of	O
HCMV	O
infection	I:C0010823
among	O
pregnant	B:C0033011
women	I:C0033011
.	O

Human	B:C3810552
cytomegalovirus	I:C3810552
(	O
Human	O
cytomegalovirus	I:C3810552
)	O
is	O
the	O
most	O
common	O
cause	O
of	O
intrauterine	O
infections	I:C1112157
worldwide	O
.	O

Human	O
cytomegalovirus	I:C3810552
(	O
Human	B:C3810552
cytomegalovirus	I:C3810552
)	O
is	O
the	O
most	O
common	O
cause	O
of	O
intrauterine	O
infections	I:C1112157
worldwide	O
.	O

Human	O
cytomegalovirus	I:C3810552
(	O
Human	O
cytomegalovirus	I:C3810552
)	O
is	O
the	O
most	O
common	O
cause	O
of	O
intrauterine	B:C1112157
infections	I:C1112157
worldwide	O
.	O

The	O
toll	B:C0670896
-	I:C0670896
like	I:C0670896
receptors	I:C0670896
(	O
toll	O
-	I:C0670896
like	I:C0670896
receptors	I:C0670896
)	O
have	O
been	O
reported	O
as	O
important	O
factors	O
in	O
immune	O
response	I:C0301872
against	O
Human	O
cytomegalovirus	I:C3810552
.	O

The	O
toll	O
-	I:C0670896
like	I:C0670896
receptors	I:C0670896
(	O
toll	B:C0670896
-	I:C0670896
like	I:C0670896
receptors	I:C0670896
)	O
have	O
been	O
reported	O
as	O
important	O
factors	O
in	O
immune	O
response	I:C0301872
against	O
Human	O
cytomegalovirus	I:C3810552
.	O

The	O
toll	O
-	I:C0670896
like	I:C0670896
receptors	I:C0670896
(	O
toll	O
-	I:C0670896
like	I:C0670896
receptors	I:C0670896
)	O
have	O
been	O
reported	O
as	O
important	O
factors	O
in	O
immune	B:C0301872
response	I:C0301872
against	O
Human	O
cytomegalovirus	I:C3810552
.	O

The	O
toll	O
-	I:C0670896
like	I:C0670896
receptors	I:C0670896
(	O
toll	O
-	I:C0670896
like	I:C0670896
receptors	I:C0670896
)	O
have	O
been	O
reported	O
as	O
important	O
factors	O
in	O
immune	O
response	I:C0301872
against	O
Human	B:C3810552
cytomegalovirus	I:C3810552
.	O

Particularly	O
,	O
TLR2	B:C1336634
,	O
TLR4	O
and	O
TLR9	O
have	O
been	O
shown	O
to	O
be	O
involved	O
in	O
antiviral	O
immunity	I:C0020964
.	O

Particularly	O
,	O
TLR2	O
,	O
TLR4	B:C1336636
and	O
TLR9	O
have	O
been	O
shown	O
to	O
be	O
involved	O
in	O
antiviral	O
immunity	I:C0020964
.	O

Particularly	O
,	O
TLR2	O
,	O
TLR4	O
and	O
TLR9	B:C1423633
have	O
been	O
shown	O
to	O
be	O
involved	O
in	O
antiviral	O
immunity	I:C0020964
.	O

Particularly	O
,	O
TLR2	O
,	O
TLR4	O
and	O
TLR9	O
have	O
been	O
shown	O
to	O
be	O
involved	O
in	O
antiviral	B:C0020964
immunity	I:C0020964
.	O

Evaluation	O
of	O
the	O
role	O
of	O
single	B:C0752046
nucleotide	I:C0752046
polymorphisms	I:C0752046
(	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
)	O
,	O
located	O
within	I:C0332285
TLR2	O
,	O
TLR4	O
and	O
TLR9	O
genes	I:C1423633
,	O
in	O
the	O
development	O
of	O
human	O
cytomegalovirus	I:C0010823
(	I:C0010823
HCMV	I:C0010823
)	I:C0010823
infection	I:C0010823
in	O
pregnant	O
women	I:C0033011
and	O
their	O
fetuses	O
and	O
neonates	O
,	O
was	O
performed	O
.	O

Evaluation	O
of	O
the	O
role	O
of	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
(	O
single	B:C0752046
nucleotide	I:C0752046
polymorphisms	I:C0752046
)	O
,	O
located	O
within	I:C0332285
TLR2	O
,	O
TLR4	O
and	O
TLR9	O
genes	I:C1423633
,	O
in	O
the	O
development	O
of	O
human	O
cytomegalovirus	I:C0010823
(	I:C0010823
HCMV	I:C0010823
)	I:C0010823
infection	I:C0010823
in	O
pregnant	O
women	I:C0033011
and	O
their	O
fetuses	O
and	O
neonates	O
,	O
was	O
performed	O
.	O

Evaluation	O
of	O
the	O
role	O
of	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
(	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
)	O
,	O
located	B:C0332285
within	I:C0332285
TLR2	O
,	O
TLR4	O
and	O
TLR9	O
genes	I:C1423633
,	O
in	O
the	O
development	O
of	O
human	O
cytomegalovirus	I:C0010823
(	I:C0010823
HCMV	I:C0010823
)	I:C0010823
infection	I:C0010823
in	O
pregnant	O
women	I:C0033011
and	O
their	O
fetuses	O
and	O
neonates	O
,	O
was	O
performed	O
.	O

Evaluation	O
of	O
the	O
role	O
of	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
(	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
)	O
,	O
located	O
within	I:C0332285
TLR2	B:C1336634
,	O
TLR4	O
and	O
TLR9	O
genes	I:C1423633
,	O
in	O
the	O
development	O
of	O
human	O
cytomegalovirus	I:C0010823
(	I:C0010823
HCMV	I:C0010823
)	I:C0010823
infection	I:C0010823
in	O
pregnant	O
women	I:C0033011
and	O
their	O
fetuses	O
and	O
neonates	O
,	O
was	O
performed	O
.	O

Evaluation	O
of	O
the	O
role	O
of	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
(	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
)	O
,	O
located	O
within	I:C0332285
TLR2	O
,	O
TLR4	B:C1336636
and	O
TLR9	O
genes	I:C1423633
,	O
in	O
the	O
development	O
of	O
human	O
cytomegalovirus	I:C0010823
(	I:C0010823
HCMV	I:C0010823
)	I:C0010823
infection	I:C0010823
in	O
pregnant	O
women	I:C0033011
and	O
their	O
fetuses	O
and	O
neonates	O
,	O
was	O
performed	O
.	O

Evaluation	O
of	O
the	O
role	O
of	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
(	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
)	O
,	O
located	O
within	I:C0332285
TLR2	O
,	O
TLR4	O
and	O
TLR9	B:C1423633
genes	I:C1423633
,	O
in	O
the	O
development	O
of	O
human	O
cytomegalovirus	I:C0010823
(	I:C0010823
HCMV	I:C0010823
)	I:C0010823
infection	I:C0010823
in	O
pregnant	O
women	I:C0033011
and	O
their	O
fetuses	O
and	O
neonates	O
,	O
was	O
performed	O
.	O

Evaluation	O
of	O
the	O
role	O
of	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
(	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
)	O
,	O
located	O
within	I:C0332285
TLR2	O
,	O
TLR4	O
and	O
TLR9	O
genes	I:C1423633
,	O
in	O
the	O
development	O
of	O
human	B:C0010823
cytomegalovirus	I:C0010823
(	I:C0010823
HCMV	I:C0010823
)	I:C0010823
infection	I:C0010823
in	O
pregnant	O
women	I:C0033011
and	O
their	O
fetuses	O
and	O
neonates	O
,	O
was	O
performed	O
.	O

Evaluation	O
of	O
the	O
role	O
of	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
(	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
)	O
,	O
located	O
within	I:C0332285
TLR2	O
,	O
TLR4	O
and	O
TLR9	O
genes	I:C1423633
,	O
in	O
the	O
development	O
of	O
human	O
cytomegalovirus	I:C0010823
(	I:C0010823
HCMV	I:C0010823
)	I:C0010823
infection	I:C0010823
in	O
pregnant	B:C0033011
women	I:C0033011
and	O
their	O
fetuses	O
and	O
neonates	O
,	O
was	O
performed	O
.	O

Evaluation	O
of	O
the	O
role	O
of	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
(	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
)	O
,	O
located	O
within	I:C0332285
TLR2	O
,	O
TLR4	O
and	O
TLR9	O
genes	I:C1423633
,	O
in	O
the	O
development	O
of	O
human	O
cytomegalovirus	I:C0010823
(	I:C0010823
HCMV	I:C0010823
)	I:C0010823
infection	I:C0010823
in	O
pregnant	O
women	I:C0033011
and	O
their	O
fetuses	B:C0015965
and	O
neonates	O
,	O
was	O
performed	O
.	O

The	O
study	O
was	O
performed	O
for	O
131	O
pregnant	B:C0033011
women	I:C0033011
,	O
including	O
66	O
patients	O
infected	O
with	O
Human	O
cytomegalovirus	I:C3810552
during	O
pregnancy	O
,	O
and	O
65	O
age	O
-	O
matched	O
control	O
pregnant	O
individuals	I:C0033011
.	O

The	O
study	O
was	O
performed	O
for	O
131	O
pregnant	O
women	I:C0033011
,	O
including	O
66	O
patients	O
infected	B:C0439663
with	O
Human	O
cytomegalovirus	I:C3810552
during	O
pregnancy	O
,	O
and	O
65	O
age	O
-	O
matched	O
control	O
pregnant	O
individuals	I:C0033011
.	O

The	O
study	O
was	O
performed	O
for	O
131	O
pregnant	O
women	I:C0033011
,	O
including	O
66	O
patients	O
infected	O
with	O
Human	B:C3810552
cytomegalovirus	I:C3810552
during	O
pregnancy	O
,	O
and	O
65	O
age	O
-	O
matched	O
control	O
pregnant	O
individuals	I:C0033011
.	O

The	O
study	O
was	O
performed	O
for	O
131	O
pregnant	O
women	I:C0033011
,	O
including	O
66	O
patients	O
infected	O
with	O
Human	O
cytomegalovirus	I:C3810552
during	O
pregnancy	B:C0032961
,	O
and	O
65	O
age	O
-	O
matched	O
control	O
pregnant	O
individuals	I:C0033011
.	O

The	O
study	O
was	O
performed	O
for	O
131	O
pregnant	O
women	I:C0033011
,	O
including	O
66	O
patients	O
infected	O
with	O
Human	O
cytomegalovirus	I:C3810552
during	O
pregnancy	O
,	O
and	O
65	O
age	O
-	O
matched	O
control	O
pregnant	B:C0033011
individuals	I:C0033011
.	O

The	O
patients	O
were	O
selected	O
to	O
the	O
study	O
,	O
based	O
on	O
serological	O
status	O
of	O
anti-HCMV	B:C0369080
IgG	I:C0369080
and	O
IgM	O
antibodies	I:C0369081
and	O
on	O
the	O
presence	O
of	O
viral	O
DNA	I:C0012939
in	O
their	O
body	O
fluids	I:C0005889
.	O

The	O
patients	O
were	O
selected	O
to	O
the	O
study	O
,	O
based	O
on	O
serological	O
status	O
of	O
anti-HCMV	O
IgG	I:C0369080
and	O
IgM	B:C0369081
antibodies	I:C0369081
and	O
on	O
the	O
presence	O
of	O
viral	O
DNA	I:C0012939
in	O
their	O
body	O
fluids	I:C0005889
.	O

The	O
patients	O
were	O
selected	O
to	O
the	O
study	O
,	O
based	O
on	O
serological	O
status	O
of	O
anti-HCMV	O
IgG	I:C0369080
and	O
IgM	O
antibodies	I:C0369081
and	O
on	O
the	O
presence	O
of	O
viral	B:C0012939
DNA	I:C0012939
in	O
their	O
body	O
fluids	I:C0005889
.	O

The	O
patients	O
were	O
selected	O
to	O
the	O
study	O
,	O
based	O
on	O
serological	O
status	O
of	O
anti-HCMV	O
IgG	I:C0369080
and	O
IgM	O
antibodies	I:C0369081
and	O
on	O
the	O
presence	O
of	O
viral	O
DNA	I:C0012939
in	O
their	O
body	B:C0005889
fluids	I:C0005889
.	O

Genotypes	O
in	O
TLR2	B:C1336634
2258	O
A	O
>	O
G	O
,	O
TLR4	O
896	O
G	O
>	O
A	O
and	O
1196	O
C	O
>	O
T	O
and	O
TLR9	O
2848	O
G	O
>	O

Genotypes	O
in	O
TLR2	O
2258	O
A	B:C0001443
>	O
G	O
,	O
TLR4	O
896	O
G	O
>	O
A	O
and	O
1196	O
C	O
>	O
T	O
and	O
TLR9	O
2848	O
G	O
>	O

Genotypes	O
in	O
TLR2	O
2258	O
A	O
>	O
G	B:C0018330
,	O
TLR4	O
896	O
G	O
>	O
A	O
and	O
1196	O
C	O
>	O
T	O
and	O
TLR9	O
2848	O
G	O
>	O

Genotypes	O
in	O
TLR2	O
2258	O
A	O
>	O
G	O
,	O
TLR4	B:C1336636
896	O
G	O
>	O
A	O
and	O
1196	O
C	O
>	O
T	O
and	O
TLR9	O
2848	O
G	O
>	O

Genotypes	O
in	O
TLR2	O
2258	O
A	O
>	O
G	O
,	O
TLR4	O
896	O
G	B:C0018330
>	O
A	O
and	O
1196	O
C	O
>	O
T	O
and	O
TLR9	O
2848	O
G	O
>	O

Genotypes	O
in	O
TLR2	O
2258	O
A	O
>	O
G	O
,	O
TLR4	O
896	O
G	O
>	O
A	B:C0001443
and	O
1196	O
C	O
>	O
T	O
and	O
TLR9	O
2848	O
G	O
>	O

Genotypes	O
in	O
TLR2	O
2258	O
A	O
>	O
G	O
,	O
TLR4	O
896	O
G	O
>	O
A	O
and	O
1196	O
C	B:C0010715
>	O
T	O
and	O
TLR9	O
2848	O
G	O
>	O

Genotypes	O
in	O
TLR2	O
2258	O
A	O
>	O
G	O
,	O
TLR4	O
896	O
G	O
>	O
A	O
and	O
1196	O
C	O
>	O
T	B:C0040077
and	O
TLR9	O
2848	O
G	O
>	O

Genotypes	O
in	O
TLR2	O
2258	O
A	O
>	O
G	O
,	O
TLR4	O
896	O
G	O
>	O
A	O
and	O
1196	O
C	O
>	O
T	O
and	O
TLR9	B:C1423633
2848	O
G	O
>	O

Genotypes	O
in	O
TLR2	O
2258	O
A	O
>	O
G	O
,	O
TLR4	O
896	O
G	O
>	O
A	O
and	O
1196	O
C	O
>	O
T	O
and	O
TLR9	O
2848	O
G	B:C0018330
>	O

A	B:C0001443
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
were	O
determined	O
by	O
self	O
-	I:C0242574
designed	I:C0242574
nested	I:C0242574
PCR	I:C0242574
-	O
RFLP	O
assays	I:C0200930
.	O

A	O
single	B:C0752046
nucleotide	I:C0752046
polymorphisms	I:C0752046
were	O
determined	O
by	O
self	O
-	I:C0242574
designed	I:C0242574
nested	I:C0242574
PCR	I:C0242574
-	O
RFLP	O
assays	I:C0200930
.	O

A	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
were	O
determined	O
by	O
self	B:C0242574
-	I:C0242574
designed	I:C0242574
nested	I:C0242574
PCR	I:C0242574
-	O
RFLP	O
assays	I:C0200930
.	O

A	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
were	O
determined	O
by	O
self	O
-	I:C0242574
designed	I:C0242574
nested	I:C0242574
PCR	I:C0242574
-	O
RFLP	B:C0200930
assays	I:C0200930
.	O

Randomly	O
selected	O
PCR	B:C0032520
products	O
,	O
representative	O
for	O
distinct	O
genotypes	O
in	O
TLR	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
,	O
were	O
confirmed	O
by	O
sequencing	O
.	O

Randomly	O
selected	O
PCR	O
products	O
,	O
representative	O
for	O
distinct	O
genotypes	O
in	O
TLR	O
single	B:C0752046
nucleotide	I:C0752046
polymorphisms	I:C0752046
,	O
were	O
confirmed	O
by	O
sequencing	O
.	O

Randomly	O
selected	O
PCR	O
products	O
,	O
representative	O
for	O
distinct	O
genotypes	O
in	O
TLR	O
single	O
nucleotide	I:C0752046
polymorphisms	I:C0752046
,	O
were	O
confirmed	O
by	O
sequencing	B:C1294197
.	O

A	O
relationship	O
between	O
the	O
genotypes	O
,	O
alleles	B:C0002085
,	O
haplotypes	O
and	O
multiple	O
variants	I:C0678941
in	O
the	O
studied	O
polymorphisms	O
,	O
and	O
the	O
occurrence	O
of	O
HCMV	O
infection	I:C0010823
in	O
pregnant	O
women	I:C0033011
and	O
their	O
offsprings	O
,	O
was	O
determined	O
,	O
using	O
a	O
logistic	O
regression	O
model	O
.	O

A	O
relationship	O
between	O
the	O
genotypes	O
,	O
alleles	O
,	O
haplotypes	O
and	O
multiple	B:C0678941
variants	I:C0678941
in	O
the	O
studied	O
polymorphisms	O
,	O
and	O
the	O
occurrence	O
of	O
HCMV	O
infection	I:C0010823
in	O
pregnant	O
women	I:C0033011
and	O
their	O
offsprings	O
,	O
was	O
determined	O
,	O
using	O
a	O
logistic	O
regression	O
model	O
.	O

A	O
relationship	O
between	O
the	O
genotypes	O
,	O
alleles	O
,	O
haplotypes	O
and	O
multiple	O
variants	I:C0678941
in	O
the	O
studied	O
polymorphisms	O
,	O
and	O
the	O
occurrence	O
of	O
HCMV	B:C0010823
infection	I:C0010823
in	O
pregnant	O
women	I:C0033011
and	O
their	O
offsprings	O
,	O
was	O
determined	O
,	O
using	O
a	O
logistic	O
regression	O
model	O
.	O

A	O
relationship	O
between	O
the	O
genotypes	O
,	O
alleles	O
,	O
haplotypes	O
and	O
multiple	O
variants	I:C0678941
in	O
the	O
studied	O
polymorphisms	O
,	O
and	O
the	O
occurrence	O
of	O
HCMV	O
infection	I:C0010823
in	O
pregnant	B:C0033011
women	I:C0033011
and	O
their	O
offsprings	O
,	O
was	O
determined	O
,	O
using	O
a	O
logistic	O
regression	O
model	O
.	O

Genotypes	O
in	O
all	O
the	O
analyzed	B:C0032529
polymorphisms	I:C0032529
preserved	O
the	O
Hardy	O
-	O
Weinberg	O
equilibrium	O
in	O
pregnant	O
women	I:C0033011
,	O
both	O
infected	O
and	O
uninfected	O
with	O
Human	O
cytomegalovirus	I:C3810552
(	O
P	O
>	O
0.050	O
)	O
.	O

Genotypes	O
in	O
all	O
the	O
analyzed	O
polymorphisms	I:C0032529
preserved	O
the	O
Hardy	O
-	O
Weinberg	O
equilibrium	O
in	O
pregnant	B:C0033011
women	I:C0033011
,	O
both	O
infected	O
and	O
uninfected	O
with	O
Human	O
cytomegalovirus	I:C3810552
(	O
P	O
>	O
0.050	O
)	O
.	O

Genotypes	O
in	O
all	O
the	O
analyzed	O
polymorphisms	I:C0032529
preserved	O
the	O
Hardy	O
-	O
Weinberg	O
equilibrium	O
in	O
pregnant	O
women	I:C0033011
,	O
both	O
infected	B:C0439663
and	O
uninfected	O
with	O
Human	O
cytomegalovirus	I:C3810552
(	O
P	O
>	O
0.050	O
)	O
.	O

Genotypes	O
in	O
all	O
the	O
analyzed	O
polymorphisms	I:C0032529
preserved	O
the	O
Hardy	O
-	O
Weinberg	O
equilibrium	O
in	O
pregnant	O
women	I:C0033011
,	O
both	O
infected	O
and	O
uninfected	O
with	O
Human	B:C3810552
cytomegalovirus	I:C3810552
(	O
P	O
>	O
0.050	O
)	O
.	O

G	B:C0018330
G	O
homozygotic	O
and	O
G	O
A	O
heterozygotic	O
status	O
in	O
TLR9	O
2848	O
G	O
>	O
A	O
SNP	O
decreased	O
significantly	O
the	O
occurrence	O
of	O
HCMV	O
infection	I:C0010823
(	O
OR	O
0.44	O
95	O
%	O
CI	O
0.21-0.94	O
in	O
the	O
dominant	O
model	I:C0026343
,	O
P	O
≤	O
0.050	O
)	O
.	O

G	O
G	B:C0018330
homozygotic	O
and	O
G	O
A	O
heterozygotic	O
status	O
in	O
TLR9	O
2848	O
G	O
>	O
A	O
SNP	O
decreased	O
significantly	O
the	O
occurrence	O
of	O
HCMV	O
infection	I:C0010823
(	O
OR	O
0.44	O
95	O
%	O
CI	O
0.21-0.94	O
in	O
the	O
dominant	O
model	I:C0026343
,	O
P	O
≤	O
0.050	O
)	O
.	O

G	O
G	O
homozygotic	O
and	O
G	B:C0018330
A	O
heterozygotic	O
status	O
in	O
TLR9	O
2848	O
G	O
>	O
A	O
SNP	O
decreased	O
significantly	O
the	O
occurrence	O
of	O
HCMV	O
infection	I:C0010823
(	O
OR	O
0.44	O
95	O
%	O
CI	O
0.21-0.94	O
in	O
the	O
dominant	O
model	I:C0026343
,	O
P	O
≤	O
0.050	O
)	O
.	O

G	O
G	O
homozygotic	O
and	O
G	O
A	B:C0001443
heterozygotic	O
status	O
in	O
TLR9	O
2848	O
G	O
>	O
A	O
SNP	O
decreased	O
significantly	O
the	O
occurrence	O
of	O
HCMV	O
infection	I:C0010823
(	O
OR	O
0.44	O
95	O
%	O
CI	O
0.21-0.94	O
in	O
the	O
dominant	O
model	I:C0026343
,	O
P	O
≤	O
0.050	O
)	O
.	O

G	O
G	O
homozygotic	O
and	O
G	O
A	O
heterozygotic	O
status	O
in	O
TLR9	B:C1423633
2848	O
G	O
>	O
A	O
SNP	O
decreased	O
significantly	O
the	O
occurrence	O
of	O
HCMV	O
infection	I:C0010823
(	O
OR	O
0.44	O
95	O
%	O
CI	O
0.21-0.94	O
in	O
the	O
dominant	O
model	I:C0026343
,	O
P	O
≤	O
0.050	O
)	O
.	O

G	O
G	O
homozygotic	O
and	O
G	O
A	O
heterozygotic	O
status	O
in	O
TLR9	O
2848	O
G	B:C0018330
>	O
A	O
SNP	O
decreased	O
significantly	O
the	O
occurrence	O
of	O
HCMV	O
infection	I:C0010823
(	O
OR	O
0.44	O
95	O
%	O
CI	O
0.21-0.94	O
in	O
the	O
dominant	O
model	I:C0026343
,	O
P	O
≤	O
0.050	O
)	O
.	O

G	O
G	O
homozygotic	O
and	O
G	O
A	O
heterozygotic	O
status	O
in	O
TLR9	O
2848	O
G	O
>	O
A	B:C0001443
SNP	O
decreased	O
significantly	O
the	O
occurrence	O
of	O
HCMV	O
infection	I:C0010823
(	O
OR	O
0.44	O
95	O
%	O
CI	O
0.21-0.94	O
in	O
the	O
dominant	O
model	I:C0026343
,	O
P	O
≤	O
0.050	O
)	O
.	O

G	O
G	O
homozygotic	O
and	O
G	O
A	O
heterozygotic	O
status	O
in	O
TLR9	O
2848	O
G	O
>	O
A	O
SNP	B:C0752046
decreased	O
significantly	O
the	O
occurrence	O
of	O
HCMV	O
infection	I:C0010823
(	O
OR	O
0.44	O
95	O
%	O
CI	O
0.21-0.94	O
in	O
the	O
dominant	O
model	I:C0026343
,	O
P	O
≤	O
0.050	O
)	O
.	O

G	O
G	O
homozygotic	O
and	O
G	O
A	O
heterozygotic	O
status	O
in	O
TLR9	O
2848	O
G	O
>	O
A	O
SNP	O
decreased	O
significantly	O
the	O
occurrence	O
of	O
HCMV	B:C0010823
infection	I:C0010823
(	O
OR	O
0.44	O
95	O
%	O
CI	O
0.21-0.94	O
in	O
the	O
dominant	O
model	I:C0026343
,	O
P	O
≤	O
0.050	O
)	O
.	O

G	O
G	O
homozygotic	O
and	O
G	O
A	O
heterozygotic	O
status	O
in	O
TLR9	O
2848	O
G	O
>	O
A	O
SNP	O
decreased	O
significantly	O
the	O
occurrence	O
of	O
HCMV	O
infection	I:C0010823
(	O
OR	O
0.44	O
95	O
%	O
CI	O
0.21-0.94	O
in	O
the	O
dominant	B:C0026343
model	I:C0026343
,	O
P	O
≤	O
0.050	O
)	O
.	O

The	O
G	B:C0018330
allele	O
in	O
TLR9	O
SNP	O
was	O
significantly	O
more	O
frequent	O
among	O
the	O
uninfected	O
pregnant	O
women	I:C0033011
than	O
among	O
the	O
infected	O
ones	O
(	O
χ	O
(	O
2	O
)	O
=	O
4.14	O
,	O
P	O
≤	O
0.050	O
)	O
.	O

The	O
G	O
allele	B:C0002085
in	O
TLR9	O
SNP	O
was	O
significantly	O
more	O
frequent	O
among	O
the	O
uninfected	O
pregnant	O
women	I:C0033011
than	O
among	O
the	O
infected	O
ones	O
(	O
χ	O
(	O
2	O
)	O
=	O
4.14	O
,	O
P	O
≤	O
0.050	O
)	O
.	O

The	O
G	O
allele	O
in	O
TLR9	B:C1423633
SNP	O
was	O
significantly	O
more	O
frequent	O
among	O
the	O
uninfected	O
pregnant	O
women	I:C0033011
than	O
among	O
the	O
infected	O
ones	O
(	O
χ	O
(	O
2	O
)	O
=	O
4.14	O
,	O
P	O
≤	O
0.050	O
)	O
.	O

The	O
G	O
allele	O
in	O
TLR9	O
SNP	B:C0752046
was	O
significantly	O
more	O
frequent	O
among	O
the	O
uninfected	O
pregnant	O
women	I:C0033011
than	O
among	O
the	O
infected	O
ones	O
(	O
χ	O
(	O
2	O
)	O
=	O
4.14	O
,	O
P	O
≤	O
0.050	O
)	O
.	O

The	O
G	O
allele	O
in	O
TLR9	O
SNP	O
was	O
significantly	O
more	O
frequent	O
among	O
the	O
uninfected	O
pregnant	B:C0033011
women	I:C0033011
than	O
among	O
the	O
infected	O
ones	O
(	O
χ	O
(	O
2	O
)	O
=	O
4.14	O
,	O
P	O
≤	O
0.050	O
)	O
.	O

The	O
G	O
allele	O
in	O
TLR9	O
SNP	O
was	O
significantly	O
more	O
frequent	O
among	O
the	O
uninfected	O
pregnant	O
women	I:C0033011
than	O
among	O
the	O
infected	B:C0439663
ones	O
(	O
χ	O
(	O
2	O
)	O
=	O
4.14	O
,	O
P	O
≤	O
0.050	O
)	O
.	O

Considering	O
other	O
polymorphisms	O
,	O
similar	O
frequencies	O
of	O
distinct	O
genotypes	O
,	O
haplotypes	O
and	O
multiple	B:C0678941
-	I:C0678941
SNP	I:C0678941
variants	I:C0678941
were	O
observed	O
between	O
the	O
studied	O
groups	O
of	O
patients	O
.	O

TLR9	B:C1423633
2848	O
G	O
>	O
A	O
SNP	O
may	O
be	O
associated	O
with	O
HCMV	O
infection	I:C0010823
in	O
pregnant	O
women	I:C0033011
.	O

TLR9	O
2848	O
G	B:C0018330
>	O
A	O
SNP	O
may	O
be	O
associated	O
with	O
HCMV	O
infection	I:C0010823
in	O
pregnant	O
women	I:C0033011
.	O

TLR9	O
2848	O
G	O
>	O
A	B:C0001443
SNP	O
may	O
be	O
associated	O
with	O
HCMV	O
infection	I:C0010823
in	O
pregnant	O
women	I:C0033011
.	O

TLR9	O
2848	O
G	O
>	O
A	O
SNP	B:C0752046
may	O
be	O
associated	O
with	O
HCMV	O
infection	I:C0010823
in	O
pregnant	O
women	I:C0033011
.	O

TLR9	O
2848	O
G	O
>	O
A	O
SNP	O
may	O
be	O
associated	O
with	O
HCMV	B:C0010823
infection	I:C0010823
in	O
pregnant	O
women	I:C0033011
.	O

TLR9	O
2848	O
G	O
>	O
A	O
SNP	O
may	O
be	O
associated	O
with	O
HCMV	O
infection	I:C0010823
in	O
pregnant	B:C0033011
women	I:C0033011
.	O

